Prognostic factors for remission in early rheumatoid arthritis: A multiparameter prospective study

113Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.

Abstract

Objective: To determine prognostic factors for remission in early rheumatoid arthritis. Methods: 191 patients with rheumatoid arthritis whose disease duration was less than one year were followed up prospectively for five years. Remission, defined by a disease activity score (DAS) of <1.6, was used as the outcome measure. Baseline clinical, laboratory, genetic, and radiographic data (with radiographic scores determined by Sharp's method, modified by van der Heijde) were obtained. Results: 48 patients (25.1%) fulfilled the remission criteria at the three year follow up visit, and 30 (15.7%) at three and five years. On univariate analysis by Fisher's exact test, remission at three years and persistent remission at five years were closely correlated with baseline DAS values, C reactive protein level, Ritchie score, health assessment questionnaire score, duration of morning stiffness, and to a lesser extent baseline total radiological scores and rheumatoid factor negativity. No significant correlation was found with sex, age, extra-articular manifestations, erythrocyte sedimentation rate, anti-cyclic citrullinated protein antibodies, anti-keratin antibodies, anti-HSP 90, anticalpastatin antibodies, antinuclear antibodies, or HLA-DRB1* genotypes. Logistic regression analysis showed that the baseline independent variables predictive of remission were low DAS, Ritchie score, morning stiffness duration, and total radiographic score. Conclusions: Baseline prognostic factors for remission in early rheumatoid arthritis were mainly clinical markers of disease activity and radiological scores.

References Powered by Scopus

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

19361Citations
N/AReaders
Get full text

Measurement of patient outcome in arthritis

4135Citations
N/AReaders
Get full text

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial

2352Citations
N/AReaders
Get full text

Cited by Powered by Scopus

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

1270Citations
N/AReaders
Get full text

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

694Citations
N/AReaders
Get full text

American college of rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

681Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gossec, L., Dougados, M., Goupille, P., Cantagrel, A., Sibilia, J., Meyer, O., … Combe, B. (2004). Prognostic factors for remission in early rheumatoid arthritis: A multiparameter prospective study. Annals of the Rheumatic Diseases, 63(6), 675–680. https://doi.org/10.1136/ard.2003.010611

Readers over time

‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

52%

Researcher 9

20%

Professor / Associate Prof. 8

17%

Lecturer / Post doc 5

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 39

78%

Agricultural and Biological Sciences 5

10%

Pharmacology, Toxicology and Pharmaceut... 3

6%

Nursing and Health Professions 3

6%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0